The letter from Dr. Barry expresses some of the controversy that the Committee on Infectious Diseases had to reconcile in determining the role of acyclovir for the therapy of varicella in the otherwise healthy child. We indeed acknowledged the proven benefit of acyclovir therapy regarding a day less of fever and a decrease in the number of skin lesions in children treated within 24 hours of onset.

This content is only available via PDF.
You do not currently have access to this content.